Loading chat...
LA HB761
Bill
Status
2/27/2026
Primary Sponsor
Stephanie Hilferty
Click for details
AI Summary
-
Increases the number of oncologists specializing in rare cancer treatments on the advisory board from two to four, bringing total board membership to seventeen
-
Extends the deadline for submitting written reports after each quarterly meeting from 30 days to 45 days
-
Changes the reporting requirement from submitting reports to the full legislature to specifically the House Committee on Insurance and Senate Committee on Insurance
-
Retains the existing board structure including representatives from the Department of Insurance, Louisiana Department of Health, medical schools, research centers, and health plan organizations
Legislative Description
Provides with respect to the advisory board created to recommend new treatments for rare cancers
HEALTH/CANCER
Last Action
Read by title, under the rules, referred to the Committee on Insurance.
3/9/2026